Siemens and Impac expand co-operation in oncology information systems
20 August 2009
Siemens Healthcare is expanding its portfolio for cancer therapy by partnering with Impac Medical Systems, Inc, part of the Swedish Elekta Group, which includes an extension of its software distribution agreement to 2016 and adding the Mosaiq software to its oncology portfolio.
partnership with IMPAC will afford Siemens customers access to Impac’s
oncology information system (OIS) in addition to the radiation therapy
Siemens. Moreover, Siemens and IMPAC will work together to develop
Under the extended agreement, Siemens will offer the Mosaiq software as
its next generation
OIS offering to Lantis, the OIS currently sold by Siemens. Siemens
Lantis customers will have
Mosaiq is an image-enabled electronic medical record for oncology that allows documentation of patient data, from diagnosis to therapy. Clinical images, lab results, and external documents can also be integrated. Support for additional business functions such as scheduling, invoicing, management reporting and analysis, among others, can also be implemented.
"We have maintained a very successful partnership with Impac since 1992 in the area of oncology information systems. In addition to cooperating on the development of interfaces for our systems for photon and electron radiation therapy, we are now working together in particle therapy. We are confident we will be able to offer our customers sustainable oncology systems which help them to optimize workflows and master the daily challenges of the hospital routine," said Holger Schmidt, CEO Oncology Care Systems, Siemens Healthcare.
"We are pleased to partner with Siemens and look forward to continuing a long and mutually beneficial relationship. We are certain Mosaiq will assist clinicians to efficiently manage even the most demanding workflows in oncology enabling our customers to deliver the best possible patient care," said Jay Hoey, IMPAC President and CEO.
Bookmark this page